In some embodiments, administration of the semaglutide and cagrilintide pharmaceutical formulations disclosed herein results in a higher HbAi c reduction, in Copoints, compared to that which results from treatment with either semaglutide as sole active ingredient or cagrilintide as sole active ingredient
Department of Health and Human Services (HHS) under Task Order # HHSP233200600001T
Ingredients: Purified Water, Butylene Glycol, Niacinamide, Propanediol, Hydroxyethyl Urea, Glycerin, Betaine, Trehalose, C12-14 Pareth-12, Caprylyl Glycol, Polyglyceryl-10 Laurate, Glutathione (1000ppm), Allantoin, Dipropylene Glycol, Fragrance, Caprylic/Capri Triglyceride, Ethylhexyl Glycerin, Adenosine, Phosphatidylcholine, Hydrogenated Lecithin, 1,2 Hexanediol, Disodium Idithio A Phytosteryl/Octyldodecyllauroyl Glutamate, EucalyptusLeaf Extract, Perilla Leaf Extract, Ceramide NP, SodiumHyaluronate, Ascorbic Acid, Tocopherol
No sostiene promesas antiedad ni regenerativas en personas